Pallas Health vs Ro.co: Oral Wegovy vs compounded semaglutide plans

Pallas Health vs Ro.co answers whether you want clinician-selected brand or compounded injectables from a 100% online program or an oral FDA-approved option. Early verdict: choose Pallas for clinician access to both brand pens and compounded semaglutide/tirzepatide with provider care included in plan pricing; choose Ro.co if you need the Wegovy pill or an injection-free FDA-approved oral GLP-1 and a $39 get-started option.
Key difference 1: Medication types and regulatory status
Pallas Health offers both FDA-approved brand-name GLP-1s such as Wegovy, Ozempic, Zepbound and Mounjaro, and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA. The source notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co is the only mainstream platform on the list offering the Wegovy pill, the FDA-approved oral GLP-1, a finished medication rather than a compounded product. Ro emphasizes the regulatory assurance of an FDA-approved finished product.
Key difference 2: Pricing entry point and ongoing cost structure
Pallas lists compounded semaglutide at $139 for the first month then $597 every 12 weeks, a $199/month average, and compounded tirzepatide at $179 first month then $897 every 12 weeks, a $299/month average. Pallas also shows cash-pay pricing for brand-name pens (examples listed). Ro.co advertises you can get started online for just $39, with ongoing branded medication pricing varying by plan and generally higher than compounded alternatives. Ro states pricing is disclosed before you complete the consultation.
Get started with Ro.co for $39
Key difference 3: Care model and platform experience
Pallas Health is 100 percent online and asynchronous in most states, with a US-licensed clinician reviewing health history to personalize a plan; a video visit is required in seven states plus Washington, D.C. Pallas includes clinician review, ongoing check-ins and care-team messaging in the plan price with no separate membership fee. Ro.co is described as an established full-service telehealth platform that prescribes FDA-approved medications after a licensed clinician review and highlights platform trust and transparent pricing before consultation.
Comparison table: Pallas Health vs Ro.co
| Criteria | Pallas Health | Ro.co |
|---|---|---|
| Medication options | Brand-name GLP-1s and compounded semaglutide/tirzepatide | Wegovy pill (FDA-approved oral GLP-1) and branded options |
| Regulatory note | Compounded meds are not FDA-approved; brand options listed | Offers FDA-approved finished oral Wegovy pill |
| Starting price | Compounded semaglutide $139 first month | Get started online for $39 |
| Ongoing pricing model | Compounded semaglutide renews $597 per 12 weeks (avg $199/mo) | Ongoing branded pricing varies by plan; disclosed before consultation |
| Care included | Provider care, check-ins and messaging included in plan price | Licensed clinician review; pricing transparency before consultation |
Other practical differences
Shipping and fulfillment: Pallas advertises free expedited discreet shipping and notes compounded medications are prepared by US-licensed compounding pharmacies. Ro.co captured information did not include shipping details on the captured page. Eligibility and payment: Pallas is cash-pay only and does not bill insurance; treatment eligibility is determined by a US-licensed clinician. Ro.co notes treatment is available only when a licensed clinician determines it is medically appropriate and that ongoing branded medication costs can be high.
Regulatory reminder
Both sources state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co emphasizes access to an FDA-approved oral option; Pallas emphasizes clinician choice between brand-name pens and compounded preparations.
Learn about the Wegovy pill on Ro.co
Conclusion: Choose based on medication format, price, and care inclusion
For a direct choice in the Pallas Health vs Ro.co comparison: Pallas is focused on giving a clinician the ability to select between brand-name pens and compounded injectables within a single intake, with provider care included in the plan price and compounded semaglutide from $139 first month then $199/mo avg. Ro.co is the standout if you need the Wegovy pill, the FDA-approved oral GLP-1, or prefer a $39 entry point and an injection-free path with pricing disclosed before consultation.
Choose Pallas Health if you want clinician access to both brand-name GLP-1s and US-compounded semaglutide or tirzepatide, all-in plan pricing that includes provider care, and free expedited shipping where offered.
Choose Ro.co if you need the Wegovy pill, prefer an FDA-approved oral GLP-1 and want to start online for $39 with branded pricing disclosed before your consultation.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons



